Similar findings have been reported in clinical populations with no change in insulin-mediated suppression of glucagon observed in populations with fasting hyperglycemia, impaired glucose tolerance, or type 2 diabetes29. This evidence concerns the gene GCG and Impaired glucose tolerance.